Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

• Trace M. Jones,
• Claudia Espitia,
• Wei Wang,
• Steffan T. Nawrocki,
• Jennifer S. Carew

Affiliations

Trace M. Jones

University of Arizona Cancer Center

Claudia Espitia

University of Arizona Cancer Center

Wei Wang

Department of Pharmacology and Toxicology, University of Arizona

Steffan T. Nawrocki

University of Arizona Cancer Center

Jennifer S. Carew

University of Arizona Cancer Center